Skip to main content
Premium Trial:

Request an Annual Quote

Clarification: Oct 1, 2003

Premium

CLARIFICATION — In the BioArray News article, “Mike Hunkapiller, ABI, Stay Mum On Details of its Expression Array System,” published on Sept. 24, 2003, reported that Applied Biosystems President Mike Hunkapiller said the company’s patent, US Patent No. 6,573,089, “Method for using and making a fiber array,” referred to a next-generation microarray. In fact, in a later discussion, a company spokeswoman said Hunkapiller was referencing the company’s announced Expression Array System as next-generation microarray technology — not the technology described in US Patent No. 6,573,089. “Patent No. 6,573,089 is not for a next-generation microarray technology,” a company spokeswoman said in an e-mail message. BioArray News is pleased to make the clarification.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.